Search research articles
Contact Us
Filters
Showing results (141-150 of 218) with videos related to
Page
of 22
Sort By:
Annales De Biologie Clinique
|
April 6, 2011
[Value of PCA3 urinary test for prostate biopsy decision: the Lyon-Sud University Hospital experience]
Virginie Vlaeminck-Guillem, Jean-Louis Campos-Fernandes, Denis Champetier, et al.
Urologia Internationalis
|
May 23, 2019
A Multicenter, Randomized, Placebo-Controlled Study Evaluating the Efficacy of a Combination of Propolis and Cranberry (Vaccinium macrocarpon) (DUAB®) in Preventing Low Urinary Tract Infection Recurrence in Women Complaining of Recurrent Cystitis
Franck Bruyère, Abdel Rahmène Azzouzi, Jean-Philippe Lavigne, et al.
European Urology Oncology
|
November 3, 2019
Improved Androgen Receptor Splice Variant 7 Detection Using a Highly Sensitive Assay to Predict Resistance to Abiraterone or Enzalutamide in Metastatic Prostate Cancer Patients
Denis Maillet, Nathalie Allioli, Julien Peron, et al.
Neurourology and Urodynamics
|
April 22, 2017
Switch to Abobotulinum toxin A may be useful in the treatment of neurogenic detrusor overactivity when intradetrusor injections of Onabotulinum toxin A failed
Florie Bottet, Benoit Peyronnet, Romain Boissier, et al.
The French Journal of Urology
|
October 10, 2025
Chemotherapy use in triplet approach for metastatic hormone-sensitive prostate cancer: French practice survey and expert opinion
Delphine Borchiellini, Gwenaelle Gravis, Emmanuel Gross, et al.
BJU International
|
January 7, 2012
The value of urinary prostate cancer gene 3 (PCA3) scores in predicting pathological features at radical prostatectomy
Xavier Durand, Evanguelos Xylinas, Camelia Radulescu, et al.
European Urology
|
November 9, 2007
Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review
Gilles Karsenty, Pierre Denys, Gérard Amarenco, et al.
Clinical Biochemistry
|
June 24, 2014
Prostate cancer biomarker annexin A3 detected in urines obtained following digital rectal examination presents antigenic variability
Céline Hamelin-Peyron, Virginie Vlaeminck-Guillem, Hader Haïdous, et al.
The Journal of Urology
|
November 4, 2022
Radioisotope-guided Lymphadenectomy for Pelvic Lymph Node Staging in Patients With Intermediate- and High-risk Prostate Cancer (The Prospective SENTINELLE Study)
François Lannes, Michael Baboudjian, Alain Ruffion, et al.
Urology
|
June 29, 2022
Non-continent Urinary Diversion (Ileal Conduit) as Salvage Therapy in Patients With Refractory Lower Urinary Tract Dysfunctions due to Multiple Sclerosis: Results of a National Cohort From the French Association of Urology (AFU) Neurourology Committee and the French-speaking Neurourology Study Group (GENULF)
Sadok Chkir, Floriane Michel, William Akakpo, et al.
Page
of 22
Search research articles
Search
Showing results (141-150 of 218) with videos related to
Sort By:
Page
of 22
Annales De Biologie Clinique
|
April 6, 2011
[Value of PCA3 urinary test for prostate biopsy decision: the Lyon-Sud University Hospital experience]
Virginie Vlaeminck-Guillem, Jean-Louis Campos-Fernandes, Denis Champetier, et al.
Urologia Internationalis
|
May 23, 2019
A Multicenter, Randomized, Placebo-Controlled Study Evaluating the Efficacy of a Combination of Propolis and Cranberry (Vaccinium macrocarpon) (DUAB®) in Preventing Low Urinary Tract Infection Recurrence in Women Complaining of Recurrent Cystitis
Franck Bruyère, Abdel Rahmène Azzouzi, Jean-Philippe Lavigne, et al.
European Urology Oncology
|
November 3, 2019
Improved Androgen Receptor Splice Variant 7 Detection Using a Highly Sensitive Assay to Predict Resistance to Abiraterone or Enzalutamide in Metastatic Prostate Cancer Patients
Denis Maillet, Nathalie Allioli, Julien Peron, et al.
Neurourology and Urodynamics
|
April 22, 2017
Switch to Abobotulinum toxin A may be useful in the treatment of neurogenic detrusor overactivity when intradetrusor injections of Onabotulinum toxin A failed
Florie Bottet, Benoit Peyronnet, Romain Boissier, et al.
The French Journal of Urology
|
October 10, 2025
Chemotherapy use in triplet approach for metastatic hormone-sensitive prostate cancer: French practice survey and expert opinion
Delphine Borchiellini, Gwenaelle Gravis, Emmanuel Gross, et al.
BJU International
|
January 7, 2012
The value of urinary prostate cancer gene 3 (PCA3) scores in predicting pathological features at radical prostatectomy
Xavier Durand, Evanguelos Xylinas, Camelia Radulescu, et al.
European Urology
|
November 9, 2007
Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review
Gilles Karsenty, Pierre Denys, Gérard Amarenco, et al.
Clinical Biochemistry
|
June 24, 2014
Prostate cancer biomarker annexin A3 detected in urines obtained following digital rectal examination presents antigenic variability
Céline Hamelin-Peyron, Virginie Vlaeminck-Guillem, Hader Haïdous, et al.
The Journal of Urology
|
November 4, 2022
Radioisotope-guided Lymphadenectomy for Pelvic Lymph Node Staging in Patients With Intermediate- and High-risk Prostate Cancer (The Prospective SENTINELLE Study)
François Lannes, Michael Baboudjian, Alain Ruffion, et al.
Urology
|
June 29, 2022
Non-continent Urinary Diversion (Ileal Conduit) as Salvage Therapy in Patients With Refractory Lower Urinary Tract Dysfunctions due to Multiple Sclerosis: Results of a National Cohort From the French Association of Urology (AFU) Neurourology Committee and the French-speaking Neurourology Study Group (GENULF)
Sadok Chkir, Floriane Michel, William Akakpo, et al.
Page
of 22